Flotation/IPO

Pinterest proceeds to IPO stage
Rakuten is among the investors in line for an exit following Pinterest’s decision to file confidentially for an initial public offering expected to value it at more than $12bn in the next four months.
Ucommune seeks home in public markets
The workspace operator is reportedly seeking a $3bn valuation in a US IPO that would allow a host of corporates including several real estate developers to exit.
SoYoung looks to mature with $300m IPO
Tencent is in line for an exit after China-based cosmetic surgery booking platform SoYoung confidentially filed to go public in the US in an offering that could raise $300m.
Stealth Bio shifts to $78m IPO
Nan Fung-backed mitochondrial therapy developer Stealth BioTherapeutics floated at the foot of its range to raise $78m, having disclosed $100m in financing last June.
Douyu cues up $500m IPO
Tencent-backed Douyu has confidentially filed to go public in the US, following another Chinese livestreaming platform, Huya, which floated last year.
Peloton begins IPO cycle
Comcast and Grace Beauty-backed interactive exercise platform Peloton Interactive is interviewing banks for an offering slated for the second half of 2019.
Harpoon snags public markets listing
The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.
Stealth to make stock market appearance
Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Other News

Choi chosen to head investment at Netmarble
Netmarble’s head of corporate strategy and senior vice-president, Chanseok Choi, has been promoted to managing director and head of investment.
Alector achieves $176m IPO
The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.
Slack officially starts journey to public markets
Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.
TCR² squares range for $80m IPO
6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.
IPO of the Year: DocuSign
A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.
Maoyan gets $250m for IPO ticket
Maoyan is floating in Hong Kong at the bottom of its range, in an offering that will provide exits to Enlight, Tencent and Meituan Dianping.

Editor's Picks

Slack officially starts journey to public markets
Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.
IPO of the Year: DocuSign
A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.
Pinterest points to April for IPO
The Rakuten-backed social media and e-commerce company, valued at more than $12bn, will select underwriters next month and could go public as soon as April.
test reg

Login